The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship

Anti-Cancer Drugs

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Zarkovic, N ^a   Zarkovic, K ^b   Grainca, S ^a   Kissel, D ^c   Jurin, M ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Johanneshaus Am Eichhof   (Germany)

Author keywords

Cytotoxic lymphocytes; Cytotoxicity; Humoral factors; Melanoma; Mistletoe; Plasma; Viscum album

Indexed keywords

CONCANAVALIN A; MITOGENIC AGENT; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER GRAFT; CANCER INHIBITION; CANCER SIZE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DRUG MECHANISM; HOST; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR; TUMOR NECROSIS; VISCUM ALBUM;

EID: 0030972085     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704001-00005     Document Type: Conference Paper

References (23)

1. Hajto T, Hostanska K, Gabius HJ: Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defence system in vivo in rabbits and patients. Cancer Res 1989, 49: 4803-4814.
2. Hajto T, Hostanska K, Fischer J, Lentzen H: Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific lectin from Viscum album plant extract. Phytomedicine 1996, 3: 129-137.
3. Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP: Characterisation of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett 1990, 51: 103-114.
4. Heiny BM, Beuth J: Mistletoe lectin as an immunomodulator: effects on β-endorphin and the release of cytokines in patients with breast cancer [in German]. Dtsch Zschr Onkol 1994, 26: 103-108.
5. Beuth J, Ko HL, Tunggal L, et al.: Dose-dependency of the immune activity of mistletoe lectin-1 [in German]. ArzneimForseh/Drug Res 1994, 44: 21-25.
6. Beuth J, Stoffel B, Ko HL, Buss B, Tunggal L, Pulverer G: Immunostimulating activity of different dosages of mistletoe lectin-1 in patients with mammary carcinoma. Arzneim-Forseh/ Drug Res 1995, 45: 505-507.
7. Franz H: Request for an impartial discussion of the so-called mistletoe therapy. Oncology 1986, 43 (suppl 1): 1-15.
8. Ganguly C, Das S: Plant lectins as inhibitors of tumor growth and modulators of host immune response. Chemotherapy 1994, 40: 272-278.
9. Hülsen H, Mechelke F: In vitro effectiveness of a mistletoe preparation on cytostatic-drug-resistant human leukemia cells. Naturwiss 1987, 74: 144-152.
10. Khwaja TA, Dias CB, Pentecost S: Recent studies on the anticancer activities of mistletoe and its alkaloids Oncology 1986, 43 (suppl 1): 42-49.
11. Kuttan G, Vasudevan D M, Kuttan R: Isolation and identification of a tumor reducing components from mistletoe extract (Iscador). Cancer Lett 1988, 41: 307-314.
12. Jurin M, Zarkovic N, Hrzenjak M, Ilic Z: Antitumorous and immuno-modulatory effects of Viscum album preparation Isorel. Oncology 1993, 50: 393-398.
13. Kissel D, Jurin M, Zarkovic N: The cytostatic and immunological effects of Viscum album [in German]. Erfahrungscheilkunde 1990, 39: 59-63.
14. Kissel D, Jurin M, Zarkovic N: Combined tumour therapy: an experimental study on the activity of Viscum album [in German]. Dtsch Zscbr Onkol 1990, 22: 134-136.
15. Zarkovic N, Trbojevic-Cepe M, Ilic Z, Hrzenjak M, Grainca S, Jurin M: Comparison of the effects of high and low concentrations of the separated Viscum album L. lectins and of the plain mistletoe plant preparation (Isorel) on the growth of normal and tumor cells in vitro. Period Biol 1995, 97: 61-67.
16. Jurin M, Zarkovic N, Borovic S, Kissel D: Immunomodulation by the Viscum album L. preparation Isorel and its antitumorous effects. In: Grundlagen der Misteltherapie. Edited by Scheer R, Becker H, Berg PA, Stuttgart: Hippocrates Verlag: 1996: 515-323.
17. Stein G, Berg PA: Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro. Eur J Clin Pharm 1994, 47: 33-38.
18. Zarkovic N, Jurin M, Dittrich W, Hartleb M, Sladoljev S, Kissel D: Comparison of the antitumorous effects of Viscum album lectins and the plain or fractional fresh plant preparation Isorel. In: Grundlagen der Misteltherapie. Edited by Scheer R, Becker H, Berg PA, Stuttgart: Hippocrates Verlag; 1996: 325-336.
19. Büssing A, Jungmann H, Suzart K, Schweitzer K: Suppression of sister chromatid exchange-inducing DNA lesions in cultured peripheral blood mononuclear cells by Viscum album L. J Exp Clin Cancer Res 1996, 15: 107-114.
20. Büssing A, Jurin M, Zarkovic N, Azhart T, Schweitzer K: DNA stabilizing activity of Viscum album L.: are mistletoe extracts indicated as supplements for conventional therapy? [in German]. Forsch Komplementärmed 1996, 3: 244-248.
21. Ribéreau-Gayon G, Jung ML, Beck JP, Anton R: Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture. Phytother Res 1995, 5: 336-339.
22. Janssen O, Scheffler A, Kabelitz D: In vitro effects of mistletoe extracts and mistletoe lectins: cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis) Arzneim-Forsch/Drug Res 1993, 43: 1221-1227.
23. Bürssing A: Induction of apoptosis by the mistletoe lectins: a review on the mechanisms of cytotoxicity by Viscum album L. Apoptosis 1996, 1; 25-32.